Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H18N2O3S |
Molecular Weight | 270.348 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
InChI
InChIKey=JLRGJRBPOGGCBT-UHFFFAOYSA-N
InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)
Molecular Formula | C12H18N2O3S |
Molecular Weight | 270.348 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:47:22 UTC 2023
by
admin
on
Sat Dec 16 15:47:22 UTC 2023
|
Record UNII |
982XCM1FOI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 310.517
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
WHO-VATC |
QA10BB03
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
LIVERTOX |
976
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
NDF-RT |
N0000008054
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
WHO-VATC |
QV04CA01
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
WHO-ATC |
A10BB03
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
WHO-ATC |
V04CA01
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
NDF-RT |
N0000175608
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
NDF-RT |
N0000008054
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
NDF-RT |
N0000008054
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
||
|
NCI_THESAURUS |
C97936
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5505
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
200-594-3
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
D014044
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
27999
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
6848
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
TOLBUTAMIDE
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
3393
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
100000091980
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
m10937
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | Merck Index | ||
|
982XCM1FOI
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
CHEMBL782
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
SUB11150MIG
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
Tolbutamide
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
87833
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
TOLBUTAMIDE
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water; soluble in 10 parts of ethanol (~750 g/l) TS; soluble in acetone R. Category: Antidiabetic. Storage: Tolbutamide should be kept in a tightly closed container, protected from light. Additional information: Even in the absence of light, Tolbutamide is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Tolbutamide contains not less than 99.0% and not more than 101.0% of C12H18N2O3S, calculated with reference to the dried substance. | ||
|
23813
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
602
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
2696
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
DTXSID8021359
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
1670003
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
10635
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | RxNorm | ||
|
C66610
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
DB01124
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY | |||
|
64-77-7
Created by
admin on Sat Dec 16 15:47:23 UTC 2023 , Edited by admin on Sat Dec 16 15:47:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MINOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |